PROGNOSTIC IMPLICATIONS OF DETERMINING 180 KDA BULLOUS PEMPHIGOID ANTIGEN (BPAG2) GENE PROTEIN PATHOLOGY IN NEONATAL JUNCTIONAL EPIDERMOLYSIS-BULLOSA/

Citation
Je. Mellerio et al., PROGNOSTIC IMPLICATIONS OF DETERMINING 180 KDA BULLOUS PEMPHIGOID ANTIGEN (BPAG2) GENE PROTEIN PATHOLOGY IN NEONATAL JUNCTIONAL EPIDERMOLYSIS-BULLOSA/, British journal of dermatology, 138(4), 1998, pp. 661-666
Citations number
28
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
00070963
Volume
138
Issue
4
Year of publication
1998
Pages
661 - 666
Database
ISI
SICI code
0007-0963(1998)138:4<661:PIOD1K>2.0.ZU;2-H
Abstract
Epidermolysis bullosa (EB) in neonates is often difficult to character ize, both in terms of making a precise diagnosis and in being able to comment accurately on the prognosis for the affected child. We present a case of a neonate with inherited mucocutaneous fragility and failur e to thrive and detail our laboratory approach for classifying the sub type of EB in this child. Mutational analysis revealed a homozygous no n-sense mutation in the gene encoding the 180 kDa bullous pemphigoid a ntigen, also known as type XVII collagen, predicting a non-lethal form of junctional EB, Identification of the underlying molecular patholog y in this case was of use in improving diagnosis, classification, mana gement and counselling.